Hikal Limited (HIKAL.BO)

287.10 -5.95 (-2.03%) At close: 03:28PM IST

Hikal Limited

Great Eastern Chambers
6th Floor Sector 11 CBD-Belapur
Navi Mumbai 400614
India
91 22 6277 0299
https://www.hikal.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 2,142

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jai Vishwanath Hiremath	Founder & Executive Chairman	50.88M	N/A	1948
Mr. Sameer Jai Hiremath	MD & Executive Director	41.89M	N/A	1974
Mr. Kuldeep Jain	Chief Financial Officer	N/A	N/A	N/A
Mr. Rajasekhar Reddy Chintakindi	Company Secretary & Compliance Officer	N/A	N/A	N/A
Mr. Anish Dilip Swadi	Senior President of Animal Health & Business Transformation	N/A	N/A	N/A
Mr. Dharmesh Panchal	Chief Technology Officer	N/A	N/A	N/A
Mr. Ratish Jha	President of Human Resources	N/A	N/A	N/A
Mr. Ravi Khadabadi	Head of Supply Chain Management & Crop Protection	N/A	N/A	N/A
Mr. Manoj Mehrotra	President of Pharmaceuticals Business	N/A	N/A	1962
Dr. T. Devanathan	Head of IP & Quality, Pharmaceuticals	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India. The company operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. It also collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. In addition, the company offers human health products, such as anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-hypertensive, anti-inflammation, and analgesic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. It also exports its products. The company operates in the United States, Canada, Europe Union, Japan, Latin America, and internationally. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Corporate governance

Hikal Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.